HOLX
$80.5
Revenue | $1074.2Mn |
Net Profits | $187.4Mn |
Net Profit Margins | 17.45% |
PE Ratio | 20 |
Hologic Inc.’s revenue fell -26.98% since last year same period to $1074.2Mn in the Q4 2022. On a quarterly growth basis, Hologic Inc. has generated 12.68% jump in its revenue since last 3-months.
Hologic Inc.’s net profit fell -62.46% since last year same period to $187.4Mn in the Q4 2022. On a quarterly growth basis, Hologic Inc. has generated 57.88% jump in its net profits since last 3-months.
Hologic Inc.’s net profit margin fell -48.59% since last year same period to 17.45% in the Q4 2022. On a quarterly growth basis, Hologic Inc. has generated 40.11% jump in its net profit margins since last 3-months.
Hologic Inc.’s price-to-earnings ratio after this Q4 2022 earnings stands at 20.
EPS Estimate Current Quarter | 0.86 |
EPS Estimate Current Year | 0.86 |
Hologic Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.86 - a 36.51% jump from last quarter’s estimates.
Hologic Inc.’s earning per share (EPS) estimates for the current year stand at 0.86.
Return on Assets (ROA) | 0.09 |
Return on Equity (ROE) | 0.21 |
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Hologic Inc.’s return on assets (ROA) stands at 0.09.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Hologic Inc.’s return on equity (ROE) stands at 0.21.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2022-07-27 | 0.71 | 0.95 | 33.8% |
2022-04-27 | 1.6 | 2.07 | 29.37% |
2022-11-15 | 0.63 | 0.82 | 30.16% |
Organisation | Hologic Inc. |
Headquarters | 250 Campus Drive, Marlborough, MA, United States, 01752 |
Employees | 6944 |
Industry | Health Technology |
CEO | Stephen MacMillan |